Biobanking Market Research Report – Forecast to 2027

Biobanking Market Research Report: By Product & Services (Equipment, Consumables, and Services), Sample Type (Blood Products), Storage Type (Manual Storage), Application (Regenerative Medicine) and End-User (Hospitals, Others) – Global Forecast till 2027

ID: MRFR/LS/4511-HCR | | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Synopsis


The biobanking market was valued at USD 950 million in 2017 and is expected to register a CAGR of 7.6% during the forecast period. The global biobanking market is majorly driven by the increasing applications in life sciences, increasing technical advanced devices, increasing demand for research activities in genomics for studying various diseases, and growing penetration by market players. Additionally, factors such as increasing government and private funding to support the regenerative medicine research are likely to boost the market growth during the forecast period.


However, factors such as higher cost of automation may hamper the growth of the market during the assessment period.


Research Methodology


 Biobanking Methodology


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Market Segmentation                                                                                                                          


The global biobanking market is segmented on the basis of products and services, sample type, storage type, application, end-user, and region. Considering products and services, the market is segmented into equipment, consumables, services, and software. Equipment is further sub-segmented into storage equipment, sample analysis equipment, sample processing equipment, sample transport equipment, and others. Consumables are further sub-segmented into storage consumables, analysis consumables, processing consumables, collection consumables, and others. Services are sub-segmented into storage services, processing services, transport services, and supply services. By sample type, the market is segmented into blood products, human tissues, cell lines, nucleic acids, biological fluids, and others. Based on storage type the market is segmented into manual storage and automated storage. On the basis of application, the market is segmented into regenerative medicine, life science research, and clinical research. By end-user, the market is segmented into hospitals, diagnostic laboratory, research centers, and others. Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas region is segmented into North America and South America.


Regional Market Summary                  


The American biobanking market is segmented into two regions, namely, North America and South America. North Americas, being the largest market, is mainly driven by the increasing number of research activities in genomics, growing investments in healthcare, and increasing patient population suffering from chronic diseases. Furthermore, the U.S. is the largest market in North America owing to the presence of a large number of hospitals-based biobanks and increasing awareness about biobanks. Canada is expected to be the fastest growing market which is driven by the overall increasing demand for cost-effective drug development. South America is expected to be the fastest growing market due to technologically advanced devices for diagnosis and increasing demand for treatment options for chronic diseases.


The European biobanking market exhibits growth with an increasing emphasis on research and developmental activities for improvement in diagnosis and treatment methods. Moreover, Germany and the U.K. are the major contributors to the growth of the market. Additionally, the increasing expenditure in healthcare by major countries in Europe also accelerates the growth of the market.   


Asia Pacific is expected to be the fastest growing market whose growth is attributed to the increasing burden of chronic diseases and increasing focus on early diagnosis and treatment of rare diseases. Furthermore, other factors contributing to the growth of the market are lifestyle changes, the influence of western culture among the adults, and addiction to smoking. Additionally, the increasing environmental pollution and exposure to harmful chemicals also attribute to the growth of the market.


The Middle East and African market for biobanking exhibits a steady rise with an increase in the number of healthcare facilities providing treatment for chronic conditions and the flourishing growth of the medical device sector especially diagnostic devices. In the African region, the awareness about biobank facilities is fueling the growth of the market.


FIGURE 1: Global Biobanking Market, by Region, 2016 (%)


 Biobanking Market


Source: Centers for Disease Control and Prevention, World Health Organization, population reference bureau, Statistics Canada, StatsCan, Centers for Medicare & Medicaid Services, U.S. Census Bureau, Organization for Economic Co-operation and Development, Expert Interview, Market Research Future Analysis, Annual report, White paper, Company Presentation


Market Segmentation & Key players


Biobanking Market, by Products & Services



  • Equipment

  • Storage Equipment

  • Sample Analysis Equipment

  • Sample Processing Equipment

  • Sample Transport Equipment

  • Consumables

  • Storage Consumables

  • Analysis Consumables

  • Processing Consumables

  • Collection Consumables

  • Services

  • Storage Services

  • Processing Services

  • Transport Services

  • Supply Services

  • Software


  Biobanking Market, by Sample Type



  • Blood Products

  • Human Tissues

  • Cell Lines

  • Nucleic Acids

  • Biological Fluids

  • Others


Biobanking Market, by Storage type



  • Manual Storage

  • Automated Storage


Biobanking Market, by Application



  • Regenerative Medicine

  • Life Science Research

  • Clinical Research

  • Others


Biobanking Market, by End-User



  • Hospitals

  • Diagnostic Laboratory

  • Research Centers

  • Others


Biobanking Market, by Region


North America



  • U.S.

  • Canada


South America


Europe



  • Western Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Spain

  • Rest of Western Europe

  • Eastern Europe


Asia Pacific



  • Japan

  • China

  • India

  • Australia

  • Republic of Korea

  • Rest of Asia Pacific


Middle East and Africa



  • United Arab Emirates

  • Saudi Arabia

  • Oman

  • Kuwait

  • Qatar

  • Rest of the Middle East & Africa


Market Players



  • Hamilton Company

  • Greiner Holding AG

  • Promega Corporation

  • Becton, Dickinson and Company

  • Merck KGaA

  • VWR Corporation

  • Tecan Trading AG

  • Thermo Fisher Scientific Inc.

  • Panasonic Healthcare Holdings Co., Ltd.

  • Qiagen N.V.

  • Brooks Automation, Inc.

  • Chart Industries, Inc.

  • Others


Intended Audience



  • Medical Device Manufacturers

  • Medical Device Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors



Frequently Asked Questions (FAQ) :


Biobanking Market valuation was USD 950 million.

Biobanking Market is projected to grow with 7.6% CAGR during the forecast period of 2018-2023.

The high cost of automation can hold back market growth.

The American market had the rule and is expected to retain it in the coming years as well.

The Asia Pacific market has the fastest growth rate.